Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25,010 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term cost effectiveness of early and sustained dual oral antiplatelet therapy with clopidogrel given for up to one year after percutaneous coronary intervention results: from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial.
Beinart SC, Kolm P, Veledar E, Zhang Z, Mahoney EM, Bouin O, Gabriel S, Jackson J, Chen R, Caro J, Steinhubl S, Topol E, Weintraub WS. Beinart SC, et al. Among authors: chen r. J Am Coll Cardiol. 2005 Sep 6;46(5):761-9. doi: 10.1016/j.jacc.2005.03.073. J Am Coll Cardiol. 2005. PMID: 16139122 Free article. Clinical Trial.
Long-term cost-effectiveness of early and sustained clopidogrel therapy for up to 1 year in patients undergoing percutaneous coronary intervention after presenting with acute coronary syndromes without ST-segment elevation.
Mahoney EM, Mehta S, Yuan Y, Jackson J, Chen R, Gabriel S, Lamy A, Culler S, Caro J, Yusuf S, Weintraub WS; CURE Study Investigators. Mahoney EM, et al. Among authors: chen r. Am Heart J. 2006 Jan;151(1):219-27. doi: 10.1016/j.ahj.2005.02.044. Am Heart J. 2006. PMID: 16368322
Influence of co-morbidity on cost of care for heart failure.
Weintraub WS, Kawabata H, Tran M, L'Italien GJ, Chen RS. Weintraub WS, et al. Am J Cardiol. 2003 Apr 15;91(8):1011-5, A8. doi: 10.1016/s0002-9149(03)00129-2. Am J Cardiol. 2003. PMID: 12686353 No abstract available.
Cost-effectiveness of early irbesartan treatment versus control (standard antihypertensive medications excluding ACE inhibitors, other angiotensin-2 receptor antagonists, and dihydropyridine calcium channel blockers) or late irbesartan treatment in patients with type 2 diabetes, hypertension, and renal disease.
Palmer AJ, Annemans L, Roze S, Lamotte M, Lapuerta P, Chen R, Gabriel S, Carita P, Rodby RA, de Zeeuw D, Parving HH. Palmer AJ, et al. Among authors: chen r. Diabetes Care. 2004 Aug;27(8):1897-903. doi: 10.2337/diacare.27.8.1897. Diabetes Care. 2004. PMID: 15277414
25,010 results
You have reached the last available page of results. Please see the User Guide for more information.